192 related articles for article (PubMed ID: 33539779)
1. MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.
Varikuti S; Verma C; Natarajan G; Oghumu S; Satoskar AR
Am J Pathol; 2021 May; 191(5):809-816. PubMed ID: 33539779
[TBL] [Abstract][Full Text] [Related]
2. Cross-presenting dendritic cells are required for control of Leishmania major infection.
Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
[TBL] [Abstract][Full Text] [Related]
3. Acute IL-4 Governs Pathogenic T Cell Responses during
Poudel B; Yorek MS; Mazgaeen L; Brown SA; Kanneganti TD; Gurung P
Immunohorizons; 2020 Sep; 4(9):546-560. PubMed ID: 32948646
[No Abstract] [Full Text] [Related]
4. Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.
Oghumu S; Stock JC; Varikuti S; Dong R; Terrazas C; Edwards JA; Rappleye CA; Holovatyk A; Sharpe A; Satoskar AR
Infect Immun; 2015 Jan; 83(1):67-76. PubMed ID: 25312956
[TBL] [Abstract][Full Text] [Related]
5. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
[TBL] [Abstract][Full Text] [Related]
6. Dectin-1 Positive Dendritic Cells Expand after Infection with
Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
Front Immunol; 2018; 9():263. PubMed ID: 29535708
[TBL] [Abstract][Full Text] [Related]
7. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
Front Immunol; 2021; 12():759021. PubMed ID: 35154068
[TBL] [Abstract][Full Text] [Related]
9. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.
Varikuti S; Natarajan G; Volpedo G; Singh B; Hamza O; Messick GV; Guerau-de-Arellano M; Papenfuss TL; Oghumu S; Satoskar AR
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182615
[TBL] [Abstract][Full Text] [Related]
11. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
13. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
[TBL] [Abstract][Full Text] [Related]
14. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
15. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response.
Chakir H; Campos-Neto A; Mojibian M; Webb JR
Microbes Infect; 2003 Apr; 5(4):241-9. PubMed ID: 12706437
[TBL] [Abstract][Full Text] [Related]
16. Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection.
Barbi J; Snider HM; Bhardwaj N; Lezama-Dávila CM; Durbin JE; Satoskar AR
FASEB J; 2009 Nov; 23(11):3990-9. PubMed ID: 19641143
[TBL] [Abstract][Full Text] [Related]
17. T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
Schwarz T; Remer KA; Nahrendorf W; Masic A; Siewe L; Müller W; Roers A; Moll H
PLoS Pathog; 2013; 9(6):e1003476. PubMed ID: 23825956
[TBL] [Abstract][Full Text] [Related]
18. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice.
Lopez Kostka S; Dinges S; Griewank K; Iwakura Y; Udey MC; von Stebut E
J Immunol; 2009 Mar; 182(5):3039-46. PubMed ID: 19234200
[TBL] [Abstract][Full Text] [Related]
19. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection.
Hurdayal R; Nieuwenhuizen NE; Revaz-Breton M; Smith L; Hoving JC; Parihar SP; Reizis B; Brombacher F
PLoS Pathog; 2013 Oct; 9(10):e1003699. PubMed ID: 24204259
[TBL] [Abstract][Full Text] [Related]
20. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
